LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

Cannabis stocks rally on Wall Street Journal report that Trump is weighing drug reclassification

Chaim Potok by Chaim Potok
August 11, 2025
in Investing
Cannabis stocks rally on Wall Street Journal report that Trump is weighing drug reclassification
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter


A worker inspects cannabis plants inside the grow room at the Aphria Inc. Diamond facility in Leamington, Ontario, Canada, on Wednesday, Jan. 13, 2021. Tilray Inc. and Aphria Inc. agreed to combine their operations, forming a new giant in the fast-growing cannabis industry.

Annie Sakkab | Bloomberg | Getty Images

Stock Chart IconStock chart icon

Cannabis ETFs, 1-day

Many stocks in the sector now sell for less than a dollar per share, meaning a move of just a few cents can lead to a large percentage change. Despite Monday’s rally, many of these stocks are far below their all-time highs.

The latest gains followed a report in the Wall Street Journal late Friday, citing people familiar with White House thinking, that Trump was weighing whether to move marijuana to a less-dangerous drug classification. Trump shared his consideration of the matter during a fundraiser at his New Jersey golf club earlier this month, the people said.

Under federal law, cannabis is currently classified as a Schedule I drug in a group that also includes heroin and cocaine. Previously, reclassification discussions have centered on moving the drug to Schedule III, a class that includes steroids and Tylenol with codeine.

Reclassification would allow marijuana companies to fall under different tax regulations and encourage investment interest, among other benefits.

A move from Schedule 1 to Schedule 3 would be “a gamechanger” for the roughly $80 billion market, said Tim Seymour, investing chief at Seymour Asset Management, on CNBC’s “Worldwide Exchange” on Monday. He noted that such a change has seemingly bipartisan support.

“It does not mean that it won’t be a complicated trade,” Seymour said. “But it does mean that you’re investing now well ahead of a lot of institutional capital if you are, in fact, investing into this sector.”

To be sure, Trump’s backing can brighten the outlook but he cannot reclassify the drug alone. The Controlled Substances Act places that authority under the Attorney General, who has historically delegated it further the administrator of the Drug Enforcement Administration.



Source link

You might also like

Brad Gerstner says Nvidia will keep rising because winning AI race is a national security matter

Buy Uber as ride-sharing giant primed for a big gain ahead, says Guggenheim

How much you can make in 2026 and still pay 0% capital gains

Share30Tweet19
Previous Post

Betting on a bullish earnings move in Cisco Systems using options

Next Post

Crypto helps emerging economies bypass legacy financial constraints

Chaim Potok

Chaim Potok

Recommended For You

Brad Gerstner says Nvidia will keep rising because winning AI race is a national security matter
Investing

Brad Gerstner says Nvidia will keep rising because winning AI race is a national security matter

October 15, 2025
Buy Uber as ride-sharing giant primed for a big gain ahead, says Guggenheim
Investing

Buy Uber as ride-sharing giant primed for a big gain ahead, says Guggenheim

October 15, 2025
How much you can make in 2026 and still pay 0% capital gains
Investing

How much you can make in 2026 and still pay 0% capital gains

October 14, 2025
Wall Street can’t seem to shake off volatility. How to generate some safe returns into year-end
Investing

Wall Street can’t seem to shake off volatility. How to generate some safe returns into year-end

October 14, 2025
Next Post
Crypto helps emerging economies bypass legacy financial constraints

Crypto helps emerging economies bypass legacy financial constraints

Related News

Podcast: Tesla optimizing FSD routes, Model 3 Long Range RWD, Ford Capri, and more

Podcast: Tesla optimizing FSD routes, Model 3 Long Range RWD, Ford Capri, and more

July 12, 2024
U.S. stocks finish higher as S&P 500, Nasdaq climb for 5th straight month

U.S. stocks finish higher as S&P 500, Nasdaq climb for 5th straight month

July 31, 2023
Carol Vorderman shares throwback of her in the 90s – and fans can’t believe it

Carol Vorderman shares throwback of her in the 90s – and fans can’t believe it

May 17, 2023

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?